← back to search

Hu Zhao

Fudan University · CN
Area of research
Molecular Biology · Surgery
Research interest
Research focused on Cancer research and Neddylation, with related work in Ubiquitin ligase, Cullin, NEDD8. Notable publications include 'Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4–CHOP–DR5 Axis in Human Esophageal Cancer Cells', 'Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target', and 'Performance of VITEK 2, E-test, Kirby–Bauer disk diffusion, and modified Kirby–Bauer disk diffusion compared to reference broth microdilution for testing tigecycline...'.
h-index
citations
338
works
7
NIH funding
primary concept
email

Recent publications

CRL3Keap1 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression
Nature Communications 2024cited by 7position: middledoi
Performance of VITEK 2, E-test, Kirby–Bauer disk diffusion, and modified Kirby–Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China
European Journal of Clinical Microbiology & Infectious Diseases 2021cited by 53position: middledoi
Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the  receptor protein of CRL2Prame complex
Cell Death and Differentiation 2021cited by 39position: middledoi
NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma
Signal Transduction and Targeted Therapy 2020cited by 29position: middledoi
Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4–CHOP–DR5 Axis in Human Esophageal Cancer Cells
Clinical Cancer Research 2016cited by 125position: middledoi
Suitability of Bactrocera dorsalis (Diptera: Tephritidae) Pupae for Spalangia endius (Hymenoptera: Pteromalidae)
Environmental Entomology 2015cited by 5position: lastdoi
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
Oncotarget 2014cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lijun Jia · Fudan University4 papers (2014–2024)Lihui Li · Fudan University3 papers (2020–2024)Lili Cai · University of Georgia3 papers (2020–2024)Wenjuan Zhang · Shanghai Medical College of Fudan University3 papers (2014–2024)Yanmei Zhang · Guangdong University of Technology3 papers (2016–2021)Yupei Liang · Shanghai Medical College of Fudan University2 papers (2016–2021)Lak Shin Jeong · Fudan University2 papers (2014–2016)Robert M. Hoffman · University of California, Los Angeles2 papers (2016–2020)Yue Liu · Fudan University2 papers (2020–2021)Shiwen Wang · Fudan University2 papers (2020–2024)Zhimin Shao · Fudan University1 papers (2021–2021)Liu‐Xiao Yang · Sun Yat-sen University1 papers (2014–2014) · 1 papers (2021–2021) · 1 papers (2016–2016)Min Li · Fudan University1 papers (2021–2021)Lijun Jia · Fudan University1 papers (2016–2016)Xiaoxue Zhao · Tianjin University1 papers (2024–2024)Junfeng Xu · South China Agricultural University1 papers (2021–2021)Jie-Yi Shi · Fudan University1 papers (2014–2014) · 1 papers (2021–2021)